|
65675cfc212eaade2e0cee98
|
2019
|
World Health Organisation
|
WHO Core Voluntary contributio...ns
more
|
2019002545
|
4.001
|
8
|
Saint Vincent and the Grenadin...es
more
|
Caribbean & Central America
|
UMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.00242208
|
0.00242208
|
0
|
0
|
0.00242208
|
0.00242208
|
|
|
|
|
Sector-wide health programmes
|
Sector-wide health programmes ...Other
more
|
100
|
CVCA_384_4.1 NATIONAL HEALTH P...OLICIES, STRATEGIES AND PLANS
more
|
CVCA_384_4.1 National health p...olicies, strategies and plans
more
|
National health policies, stra...tegies and plans
more
|
0
|
12110
|
Health policy and administrati...ve management
more
|
3.8
|
I.2.a. Health, General
|
41143
|
World Health Organisation - co...re voluntary contributions account
more
|
WHO-CVCA
|
|
3.8
|
|
65675cfc212eaade2e0cee99
|
2019
|
World Health Organisation
|
WHO Core Voluntary contributio...ns
more
|
2019002747
|
2.003
|
8
|
Myanmar
|
South & Central Asia
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.00899997
|
0.00899997
|
0
|
0
|
0.00899997
|
0.00899997
|
0
|
0
|
0
|
0
|
Other health problems
|
Other health problems Other
|
100
|
CVCA_635_2.3 VIOLENCE AND INJU...RIES
more
|
CVCA_635_2.3 Violence and inju...ries
more
|
Violence and injuries
|
0
|
12110
|
Health policy and administrati...ve management
more
|
3.2
|
I.2.a. Health, General
|
41143
|
World Health Organisation - co...re voluntary contributions account
more
|
WHO-CVCA
|
|
3.2
|
|
65675cfc212eaade2e0cee9a
|
2019
|
World Health Organisation
|
WHO Core Voluntary contributio...ns
more
|
2019002740
|
12.003
|
8
|
Bhutan
|
South & Central Asia
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0689768
|
0.0689768
|
0
|
0
|
0.0689768
|
0.0689768
|
|
|
|
|
Sector-wide health programmes
|
Sector-wide health programmes ...Other
more
|
100
|
CVCA_630_12.3 HEALTH EMERGENCY... INFORMATION AND RISK ASSESSMENT
more
|
CVCA_630_12.3 Health emergency... information and risk assessment
more
|
Health emergency information a...nd risk assessment
more
|
0
|
74020
|
Multi-hazard response prepared...ness
more
|
3.d
|
VIII.3. Disaster Prevention & ...Preparedness
more
|
41143
|
World Health Organisation - co...re voluntary contributions account
more
|
WHO-CVCA
|
|
3.d
|
|
65675cfc212eaade2e0cee9b
|
2019
|
UNFPA
|
UNFPA
|
2019002738
|
|
8
|
Kosovo
|
Europe
|
LMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0313055
|
0.0313055
|
0
|
0
|
0.0313055
|
0.0313055
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
POPULATION AND DEVELPMENT
|
Population and Develpment
|
By 2030, build on existing ini...tiatives to develop measurements of progress on sustainable development that complement gross domestic product, and support statistical capacity-building in developing countries
more
|
Population and Develpment
|
16062
|
Statistical capacity building
|
|
I.6. Other Social Infrastructu...re & Services
more
|
|
|
|
|
17.9
|
|
65675cfc212eaade2e0cee9c
|
2019
|
World Health Organisation
|
WHO Core Voluntary contributio...ns
more
|
2019002739
|
12.002
|
8
|
Bhutan
|
South & Central Asia
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0162798
|
0.0162798
|
0
|
0
|
0.0162798
|
0.0162798
|
|
|
|
|
Communicable diseases
|
Pandemic preparedness / health... security
more
|
100
|
CVCA_630_12.2 COUNTRY HEALTH E...MERGENCY PREPAREDNESS AND THE INTERNATIONAL HEALTH REGULATIONS (2005)
more
|
CVCA_630_12.2 Country health e...mergency preparedness and the International Health Regulations (2005)
more
|
Country health emergency prepa...redness and the International Health Regulations (2005)
more
|
0
|
74020
|
Multi-hazard response prepared...ness
more
|
3.d
|
VIII.3. Disaster Prevention & ...Preparedness
more
|
41143
|
World Health Organisation - co...re voluntary contributions account
more
|
WHO-CVCA
|
|
3.d
|
|
65675cfc212eaade2e0cee9d
|
2019
|
World Health Organisation
|
WHO Core Voluntary contributio...ns
more
|
2019002744
|
1.005
|
8
|
Myanmar
|
South & Central Asia
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.29986
|
0.29986
|
0
|
0
|
0.29986
|
0.29986
|
|
|
|
|
Child health
|
Immunisation
|
100
|
CVCA_635_1.5 VACCINE-PREVENTAB...LE DISEASES
more
|
CVCA_635_1.5 Vaccine-preventab...le diseases
more
|
Vaccine-preventable diseases
|
0
|
12250
|
Infectious disease control
|
3.b
|
I.2.b. Basic Health
|
41143
|
World Health Organisation - co...re voluntary contributions account
more
|
WHO-CVCA
|
|
3.b
|
|
65675cfc212eaade2e0cee9e
|
2019
|
World Health Organisation
|
WHO Core Voluntary contributio...ns
more
|
2019002743
|
1.004
|
8
|
Myanmar
|
South & Central Asia
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.186908
|
0.186908
|
0
|
0
|
0.186908
|
0.186908
|
|
|
|
|
Communicable diseases
|
NTDs
|
100
|
CVCA_635_1.4 NEGLECTED TROPICA...L DISEASES
more
|
CVCA_635_1.4 Neglected tropica...l diseases
more
|
Neglected tropical diseases
|
0
|
12250
|
Infectious disease control
|
3.3
|
I.2.b. Basic Health
|
41143
|
World Health Organisation - co...re voluntary contributions account
more
|
WHO-CVCA
|
|
3.3
|
|
65675cfc212eaade2e0cee9f
|
2019
|
UNFPA
|
UNFPA
|
2019003842
|
|
8
|
Moldova
|
Europe
|
LMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.00059603
|
0.00059603
|
0
|
0
|
0.00059603
|
0.00059603
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
POPULATION AND DEVELPMENT
|
Population and Develpment
|
By 2030, build on existing ini...tiatives to develop measurements of progress on sustainable development that complement gross domestic product, and support statistical capacity-building in developing countries
more
|
Population and Develpment
|
16062
|
Statistical capacity building
|
|
I.6. Other Social Infrastructu...re & Services
more
|
|
|
|
|
17.9
|
|
65675cfc212eaade2e0ceea0
|
2019
|
UNFPA
|
UNFPA
|
2019003843
|
|
8
|
Moldova
|
Europe
|
LMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0503655
|
0.0503655
|
0
|
0
|
0.0503655
|
0.0503655
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
POPULATION AND DEVELPMENT
|
Population and Develpment
|
Support positive economic, soc...ial and environmental links between urban, per-urban and rural areas by strengthening national and regional development planning
more
|
Population and Develpment
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
|
|
|
|
11.a
|
|
65675cfc212eaade2e0ceea1
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003836
|
MRC_CHN_MR/L018942/1
|
1
|
China (People's Republic of)
|
Far East Asia
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0686192
|
0.0686192
|
0
|
0
|
0.0686192
|
0.0686192
|
0
|
0.0686192
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
THE IMPACT OF IFTIM3 GENETIC V...ARIATION ON INFLUENZA VIRUS INFECTION, IMMUNE RESPONSES AND DISEASE OUTCOME
more
|
The impact of IFTIM3 genetic v...ariation on Influenza virus infection, immune responses and disease outcome
more
|
The impact of IFTIM3 genetic v...ariation on Influenza virus infection, immune responses and disease outcome
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfc212eaade2e0ceea2
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003835
|
MRC_AA_MR/L01839X/1
|
3
|
Africa, regional
|
Africa
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0594282
|
0.0594282
|
0
|
0
|
0.0594282
|
0.0594282
|
0
|
0.0594282
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
NOVEL IMMUNOPROTEOMIC STRATEGI...ES TO DEVELOP A POLYSPECIFIC, NONCOLD CHAIN LIQUID SNAKE ANTIVENOM WITH UNPARALLELED SUBSAHARAN AFRICAN EFFICACY
more
|
Novel immunoproteomic strategi...es to develop a polyspecific, noncold chain liquid snake antivenom with unparalleled subSaharan African efficacy
more
|
Novel immunoproteomic strategi...es to develop a polyspecific, noncold chain liquid snake antivenom with unparalleled subSaharan African efficacy
more
|
NTDs
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfc212eaade2e0ceea3
|
2019
|
UNFPA
|
UNFPA
|
2019003841
|
|
8
|
Moldova
|
Europe
|
LMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0272057
|
0.0272057
|
0
|
0
|
0.0272057
|
0.0272057
|
|
|
|
|
Classified as not health-speci...fic activity
more
|
|
100
|
POPULATION AND DEVELPMENT
|
Population and Develpment
|
By 2030, build on existing ini...tiatives to develop measurements of progress on sustainable development that complement gross domestic product, and support statistical capacity-building in developing countries
more
|
Population and Develpment
|
13010
|
Population policy and administ...rative management
more
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
|
|
|
|
17.9
|
|
65675cfc212eaade2e0ceea4
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003834
|
MRC_GMB_MR/P012019/1
|
1
|
Gambia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.269384
|
0.269384
|
0
|
0
|
0.269384
|
0.269384
|
0
|
0.269384
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
UNDERSTANDING THE NUTRITIONAL ...REGULATION OF 'HEALTHY' FETAL AND INFANT GROWTH AND DEVELOPMENT
more
|
Understanding the nutritional ...regulation of 'healthy' fetal and infant growth and development
more
|
Understanding the nutritional ...regulation of 'healthy' fetal and infant growth and development
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfc212eaade2e0ceea5
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003839
|
MRC_NS_MR/P025927/1
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.509008
|
0.509008
|
0
|
0
|
0.509008
|
0.509008
|
0
|
0.509008
|
0
|
0
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
INTERNATIONAL RESEARCH PROGRAM...ME ON PSYCHOSES IN DIVERSE SETTINGS (INTREPID II)
more
|
International Research Program...me on Psychoses In Diverse Settings (INTREPID II)
more
|
International Research Program...me on Psychoses In Diverse Settings (INTREPID II)
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfc212eaade2e0ceea6
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003833
|
MRC_NS_MR/P011292/1
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.21902
|
0.21902
|
0
|
0
|
0.21902
|
0.21902
|
0
|
0.21902
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
ROLE OF MYCOBACTERIUM LEPRAE P...ROTEINS AND RNAS IN INITIATING NEUROPATHY
more
|
Role of Mycobacterium leprae p...roteins and RNAs in initiating neuropathy
more
|
Role of Mycobacterium leprae p...roteins and RNAs in initiating neuropathy
more
|
NTDs
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfc212eaade2e0ceea7
|
2019
|
World Health Organisation
|
WHO Core Voluntary contributio...ns
more
|
2019002544
|
3.001
|
8
|
Saint Vincent and the Grenadin...es
more
|
Caribbean & Central America
|
UMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.00242208
|
0.00242208
|
0
|
0
|
0.00242208
|
0.00242208
|
|
|
|
|
Projects of reproductive healt...h
more
|
Reproductive Health General
|
100
|
CVCA_384_3.1 REPRODUCTIVE, MAT...ERNAL, NEWBORN, CHILD AND ADOLESCENT HEALTH
more
|
CVCA_384_3.1 Reproductive, mat...ernal, newborn, child and adolescent health
more
|
Reproductive, maternal, newbor...n, child and adolescent health
more
|
0
|
13020
|
Reproductive health care
|
3.8
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
41143
|
World Health Organisation - co...re voluntary contributions account
more
|
WHO-CVCA
|
|
3.8
|
|
65675cfc212eaade2e0ceea8
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003831
|
MRC_BFA_MR/P01111X/1
|
1
|
Burkina Faso
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.248417
|
0.248417
|
0
|
0
|
0.248417
|
0.248417
|
0
|
0.248417
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
NEARINFRARED SPECTROSCOPY: A O...NESTOPSHOP FOR MOSQUITO EPIDEMIOLOGICAL MONITORING?
more
|
NearInfrared Spectroscopy: A O...neStopShop for Mosquito Epidemiological Monitoring?
more
|
NearInfrared Spectroscopy: A O...neStopShop for Mosquito Epidemiological Monitoring?
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfc212eaade2e0ceea9
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003825
|
MRC_COL_MR/R011176/1
|
1
|
Colombia
|
South America
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.329876
|
0.329876
|
0
|
0
|
0.329876
|
0.329876
|
0
|
0.329876
|
0
|
0
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
USING GAME THEORY TO ASSESS TH...E EFFECTS OF SOCIAL NORMS AND SOCIAL NETWORKS ON ADOLESCENT SMOKING IN SCHOOLS: A PROOF OF CONCEPT STUDY
more
|
Using Game Theory to assess th...e effects of social norms and social networks on adolescent smoking in schools: a proof of concept study
more
|
Using Game Theory to assess th...e effects of social norms and social networks on adolescent smoking in schools: a proof of concept study
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfc212eaade2e0ceeaa
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003830
|
MRC_TZA_MR/M011941/1
|
1
|
Tanzania
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0980076
|
0.0980076
|
0
|
0
|
0.0980076
|
0.0980076
|
0
|
0.0980076
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
PERIDOMESTIC BEHAVIOUR OF AFRI...CAN MALARIA VECTORS AND THE IMPACT OF INSECTICIDES
more
|
Peridomestic behaviour of Afri...can malaria vectors and the impact of insecticides
more
|
Peridomestic behaviour of Afri...can malaria vectors and the impact of insecticides
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfc212eaade2e0ceeab
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003827
|
MRC_AA_MR/L009242/1
|
3
|
Africa, regional
|
Africa
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0338756
|
0.0338756
|
0
|
0
|
0.0338756
|
0.0338756
|
0
|
0.0338756
|
0
|
0
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
BIOMASS REDUCTION AND ENVIRONM...ENTAL AIR TOWARDS HEALTH EFFECTS IN AFRICA BREATHE PARTNERSHIP
more
|
Biomass Reduction and Environm...ental Air Towards Health Effects in Africa BREATHE partnership
more
|
Biomass Reduction and Environm...ental Air Towards Health Effects in Africa BREATHE partnership
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfc212eaade2e0ceeac
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003828
|
MRC_NS_MR/M011569/1
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.590124
|
0.590124
|
0
|
0
|
0.590124
|
0.590124
|
0
|
0.590124
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
EXPERIMENTAL HUMAN PNEUMOCOCCA...L CARRIAGE TO DETERMINE OPTIMAL PROTECTION FROM CARRIAGE AND MECHANISMS OF MUCOSAL IMMUNISATION AGAINST DISEASE
more
|
Experimental Human Pneumococca...l Carriage to determine optimal protection from carriage and mechanisms of mucosal immunisation against disease
more
|
Experimental Human Pneumococca...l Carriage to determine optimal protection from carriage and mechanisms of mucosal immunisation against disease
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfc212eaade2e0ceead
|
2019
|
World Health Organisation
|
WHO Core Voluntary contributio...ns
more
|
2019002546
|
12.001
|
8
|
Saint Vincent and the Grenadin...es
more
|
Caribbean & Central America
|
UMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.00242206
|
0.00242206
|
0
|
0
|
0.00242206
|
0.00242206
|
|
|
|
|
Communicable diseases
|
Communicable diseases Other
|
100
|
CVCA_384_12.1 INFECTIOUS HAZAR...D MANAGEMENT
more
|
CVCA_384_12.1 Infectious hazar...d management
more
|
Infectious hazard management
|
0
|
74020
|
Multi-hazard response prepared...ness
more
|
3.d
|
VIII.3. Disaster Prevention & ...Preparedness
more
|
41143
|
World Health Organisation - co...re voluntary contributions account
more
|
WHO-CVCA
|
|
3.d
|
|
65675cfd212eaade2e0ceeae
|
2019
|
World Health Organisation
|
WHO Core Voluntary contributio...ns
more
|
2019002752
|
4.001
|
8
|
Myanmar
|
South & Central Asia
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0210522
|
0.0210522
|
0
|
0
|
0.0210522
|
0.0210522
|
|
|
|
|
Sector-wide health programmes
|
Sector-wide health programmes ...Other
more
|
100
|
CVCA_635_4.1 NATIONAL HEALTH P...OLICIES, STRATEGIES AND PLANS
more
|
CVCA_635_4.1 National health p...olicies, strategies and plans
more
|
National health policies, stra...tegies and plans
more
|
0
|
12110
|
Health policy and administrati...ve management
more
|
3.8
|
I.2.a. Health, General
|
41143
|
World Health Organisation - co...re voluntary contributions account
more
|
WHO-CVCA
|
|
3.8
|
|
65675cfd212eaade2e0ceeaf
|
2019
|
World Health Organisation
|
WHO Core Voluntary contributio...ns
more
|
2019002754
|
4.003
|
8
|
Myanmar
|
South & Central Asia
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.005678
|
0.005678
|
0
|
0
|
0.005678
|
0.005678
|
|
|
|
|
Sector-wide health programmes
|
Access to medical products
|
100
|
CVCA_635_4.3 ACCESS TO MEDICIN...ES AND HEALTH TECHNOLOGIES, AND STRENGTHENING REGULATORY CAPACITY
more
|
CVCA_635_4.3 Access to medicin...es and health technologies, and strengthening regulatory capacity
more
|
Access to medicines and health... technologies, and strengthening regulatory capacity
more
|
|
12220
|
Basic health care
|
3.8
|
I.2.b. Basic Health
|
41143
|
World Health Organisation - co...re voluntary contributions account
more
|
WHO-CVCA
|
|
3.8
|
|
65675cfd212eaade2e0ceeb0
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019002753
|
GCRF_RS_TZA_ICA_ICA\R1\191238
|
1
|
Tanzania
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0929045
|
0.0929045
|
0
|
0
|
0.0929045
|
0.0929045
|
0
|
0.0929045
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
AIMIRS: AN ONLINE PLATFORM FOR... MALARIA VECTOR SURVEILLANCE IN AFRICA USING ARTIFICIAL INTELLIGENCE AND MOSQUITO INFRARED SPECTROSCOPY
more
|
AIMIRS: An Online Platform for... Malaria Vector Surveillance in Africa using Artificial Intelligence and Mosquito InfraRed Spectroscopy
more
|
Research Grant Collaboration ...between UK and Tanzania. Using infrared and machine learning to estimate the age of mosquitoes, a knowledge gap that currently hinders our ability to predict and measure impact of mosquito control interventions. SDG 3.
more
|
|
12262
|
Malaria control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
|
65675cfd212eaade2e0ceeb1
|
2019
|
World Health Organisation
|
WHO Core Voluntary contributio...ns
more
|
2019002748
|
2.004
|
8
|
Myanmar
|
South & Central Asia
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0412801
|
0.0412801
|
0
|
0
|
0.0412801
|
0.0412801
|
|
|
|
|
Other health problems
|
Other health problems Other
|
100
|
CVCA_635_2.4 DISABILITY AND RE...HABILITATION
more
|
CVCA_635_2.4 Disability and re...habilitation
more
|
Disability and rehabilitation
|
0
|
12110
|
Health policy and administrati...ve management
more
|
3.8
|
I.2.a. Health, General
|
41143
|
World Health Organisation - co...re voluntary contributions account
more
|
WHO-CVCA
|
|
3.8
|
|
65675cfd212eaade2e0ceeb2
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003852
|
MRC_AA_MR/R019142/1
|
1
|
Africa, regional
|
Africa
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.189948
|
0.189948
|
0
|
0
|
0.189948
|
0.189948
|
0
|
0.189948
|
0
|
0
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
A PRAGMATIC APPROACH TO THE PR...EVENTION OF GESTATIONAL DIABETES AND PREECLAMPSIA IN OBESE PREGNANT WOMEN IN RESOURCE POOR SETTINGS
more
|
A pragmatic approach to the pr...evention of gestational diabetes and preeclampsia in obese pregnant women in resource poor settings
more
|
A pragmatic approach to the pr...evention of gestational diabetes and preeclampsia in obese pregnant women in resource poor settings
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceeb3
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003853
|
MRC_UGA_MR/R02118X/1
|
1
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.735432
|
0.735432
|
0
|
0
|
0.735432
|
0.735432
|
0
|
0.735432
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
POPULATION DIFFERENCES IN VACC...INE RESPONSE: THE ROLE, REVERSIBILITY AND MEDIATORS OF IMMUNOMODULATION BY CHRONIC PARASITIC INFECTIONS IN THE TROPICS
more
|
Population differences in vacc...ine response: the role, reversibility and mediators of immunomodulation by chronic parasitic infections in the tropics
more
|
Population differences in vacc...ine response: the role, reversibility and mediators of immunomodulation by chronic parasitic infections in the tropics
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceeb4
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003851
|
MRC_IND_MR/R018456/1
|
1
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.121748
|
0.121748
|
0
|
0
|
0.121748
|
0.121748
|
0
|
0.121748
|
0
|
0
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
TOQUIT: DEVELOPMENT AND PRELIM...INARY EVALUATION OF A TECHNOLOGY ASSISTED TOBACCO CESSATION INTERVENTION IN INDIA
more
|
ToQuit: Development and prelim...inary evaluation of a technology assisted tobacco cessation intervention in India
more
|
ToQuit: Development and prelim...inary evaluation of a technology assisted tobacco cessation intervention in India
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceeb5
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003847
|
MRC_NS_MR/R015236/1
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.194742
|
0.194742
|
0
|
0
|
0.194742
|
0.194742
|
0
|
0.194742
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
CLINICAL EVALUATION OF PRIMET...ARGET IMMUNISATION
more
|
Clinical Evaluation of PrimeT...arget Immunisation
more
|
Clinical Evaluation of PrimeT...arget Immunisation
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceeb6
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003849
|
MRC_IND_MR/R018278/1
|
1
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0948165
|
0.0948165
|
0
|
0
|
0.0948165
|
0.0948165
|
0
|
0.0948165
|
0
|
0
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
YOGA PROGRAMME FOR TYPE2 DIABE...TES PREVENTION (YOGADP) AMONG HIGHRISK PEOPLE IN INDIA: INTERVENTION DEVELOPMENT AND FEASIBILITY STUDY
more
|
Yoga programme for type2 diabe...tes prevention (YOGADP) among highrisk people in India: intervention development and feasibility study
more
|
Yoga programme for type2 diabe...tes prevention (YOGADP) among highrisk people in India: intervention development and feasibility study
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceeb7
|
2019
|
UNICEF
|
UNICEF
|
2019003869
|
4550/A0/05/201/003
|
8
|
Tanzania
|
South of Sahara
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.187
|
0.187
|
0
|
0
|
0.187
|
0.187
|
0
|
0
|
0
|
0
|
Child health
|
Child health Other
|
100
|
PARENTS AND CAREGIVERS HAVE IM...PROVED CAPACITY
more
|
PARENTS AND CAREGIVERS HAVE IM...PROVED CAPACITY
more
|
|
|
12250
|
Infectious disease control
|
5;3
|
I.2.b. Basic Health
|
41122
|
United Nations Children's Fund
|
UNICEF
|
|
5;3
|
|
65675cfd212eaade2e0ceeb8
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003866
|
MRC_NS_MR/S000844/1
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.208206
|
0.208206
|
0
|
0
|
0.208206
|
0.208206
|
0
|
0.208206
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
REGULATION OF HIV1 AND EBOLA V...IRUS REPLICATION BY CPG DINUCLEOTIDES, ZAP AND TRIM25
more
|
Regulation of HIV1 and Ebola v...irus replication by CpG dinucleotides, ZAP and TRIM25
more
|
Evaluation of a Mask Aerosol S...ampling System (MASS) as an Active Case Finding Approach Focused on Infectious TB in LowResource Settings.
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceeb9
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003868
|
MRC_AP_MR/R023247/1
|
1
|
Asia, regional
|
Asia
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.13645
|
0.13645
|
0
|
0
|
0.13645
|
0.13645
|
0
|
0.13645
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
MECHANISMS OF INSULIN RESISTAN...CE IN SOUTH ASIANS (MIRSA): THE ROLES OF SKELETAL MUSCLE MICROVASCULATURE AND MITOCHONDRIAL METABOLISM
more
|
Mechanisms of insulin resistan...ce in South Asians (MIRSA): the roles of skeletal muscle microvasculature and mitochondrial metabolism
more
|
The Mycobacterium tuberculosis... Cell Envelope: unravelling complex cell wall assembly, degradation and recycling pathways
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceeba
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003870
|
MRC_AA_MR/S005242/1
|
1
|
Africa, regional
|
Africa
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.191638
|
0.191638
|
0
|
0
|
0.191638
|
0.191638
|
0
|
0.191638
|
0
|
0
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
L. ZUHLKE, UNIVERSITY OF CAPE ...TOWN: ETIOLOGICAL, INTERVENTION AND OUTCOME STUDIES IN AFRICAN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH HEART DISEASE
more
|
L. Zuhlke, University of Cape ...Town: Etiological, intervention and outcome studies in African children, adolescents and young adults with heart disease
more
|
MRC/African Research Leaders a...ward to work on Rheumatic heart disease (RHD), Congenital heart disease (CHD) and Heart disease associated with HIV in children and young adults which causes major health problems in millions of children and young adults in Africa and other parts of the developing world.
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceebb
|
2019
|
UNICEF
|
UNICEF
|
2019003867
|
3300/A0/06/001/002
|
8
|
Pakistan
|
South & Central Asia
|
LMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.029
|
0.029
|
0
|
0
|
0.029
|
0.029
|
0
|
0
|
0
|
0
|
Child health
|
Child health General
|
100
|
OUTPUT 2: INTEGRATED NEWBORN A...ND CHILD-HEALTH INTERVENTIONS
more
|
OUTPUT 2: INTEGRATED NEWBORN A...ND CHILD-HEALTH INTERVENTIONS
more
|
|
|
12250
|
Infectious disease control
|
5;3
|
I.2.b. Basic Health
|
41122
|
United Nations Children's Fund
|
UNICEF
|
|
5;3
|
|
65675cfd212eaade2e0ceebc
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003871
|
MRC_AA_MR/S005293/1
|
1
|
Africa, regional
|
Africa
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.375535
|
0.375535
|
0
|
0
|
0.375535
|
0.375535
|
0
|
0.375535
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
I. ADETIFA, KEMRIWELLCOME TRUS...T RESEARCH PROGRAMME, KENYA, SEROEPIDEMIOLOGY FOR MONITORING VACCINATION AND INFORMING VACCINE POLICY IN AFRICA
more
|
I. Adetifa, KEMRIWellcome Trus...t Research Programme, Kenya, Seroepidemiology for monitoring vaccination and informing vaccine policy in Africa
more
|
MRC/African Research Leaders a...ward with the aim to demonstrate the utility of seroepidemiology for monitoring vaccination and profiling population immunity for vaccine policy within Africa
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceebd
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003862
|
MRC_IND_MR/R025347/1
|
1
|
India
|
South & Central Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
1.08904
|
1.08904
|
0
|
0
|
1.08904
|
1.08904
|
0
|
1.08904
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
DEVELOPMENT OF A LIVE ATTENUAT...ED VACCINE AGAINST SALMONELLA PARATYPHI (VASP)
more
|
Development of a Live Attenuat...ed Vaccine Against Salmonella Paratyphi (VASP)
more
|
Development of a Live Attenuat...ed Vaccine Against Salmonella Paratyphi (VASP)
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceebe
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003859
|
MRC_ETH_MR/R023697/1
|
1
|
Ethiopia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.514215
|
0.514215
|
0
|
0
|
0.514215
|
0.514215
|
0
|
0.514215
|
0
|
0
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
INDIGO (INTERNATIONAL STUDY OF... DISCRIMINATION AND STIGMA OUTCOMES)
more
|
Indigo (International study of... discrimination and stigma outcomes)
more
|
Indigo (International study of... discrimination and stigma outcomes)
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceebf
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003861
|
MRC_NS_MR/R020787/1
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.127625
|
0.127625
|
0
|
0
|
0.127625
|
0.127625
|
0
|
0.127625
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
INFORMING SHIGELLOSIS TREATMEN...T AND MANAGEMENT IN RESOURCEPOOR SETTINGS THROUGH PATHOGEN GENOMICS
more
|
Informing shigellosis treatmen...t and management in resourcepoor settings through pathogen genomics
more
|
Informing shigellosis treatmen...t and management in resourcepoor settings through pathogen genomics
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceec0
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003864
|
MRC_NS_MR/S000453/1
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.275828
|
0.275828
|
0
|
0
|
0.275828
|
0.275828
|
0
|
0.275828
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
WORMBASE: EXPANDING THE REFERE...NCE RESOURCE FOR HELMINTH RESEARCH
more
|
WormBase: expanding the refere...nce resource for helminth research
more
|
WormBase: expanding the refere...nce resource for helminth research
more
|
NTDs
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceec1
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003858
|
MRC_AA_MR/R023360/1
|
1
|
Africa, regional
|
Africa
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.409102
|
0.409102
|
0
|
0
|
0.409102
|
0.409102
|
0
|
0.409102
|
0
|
0
|
Child health
|
Child health Research and Deve...lopment
more
|
100
|
INFECTION, INFLAMMATION AND HE...PCIDINMEDIATED IRON DEFICIENCY ANAEMIA IN AFRICAN CHILDREN
more
|
Infection, inflammation and he...pcidinmediated iron deficiency anaemia in African children
more
|
Infection, inflammation and he...pcidinmediated iron deficiency anaemia in African children
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceec2
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003863
|
MRC_CMR_MR/R025401/1
|
1
|
Cameroon
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
1.27405
|
1.27405
|
0
|
0
|
1.27405
|
1.27405
|
0
|
1.27405
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
MICA: PRECLINICAL DEVELOPMENT ...OF A SMALL MOLECULE ANTIWOLBACHIA CANDIDATE MACROFILARICIDE DRUG
more
|
MICA: Preclinical development ...of a small molecule antiwolbachia candidate macrofilaricide drug
more
|
MICA: Preclinical development ...of a small molecule antiwolbachia candidate macrofilaricide drug
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceec3
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003856
|
MRC_ZAF_MR/R023050/1
|
1
|
South Africa
|
South of Sahara
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.105443
|
0.105443
|
0
|
0
|
0.105443
|
0.105443
|
0
|
0.105443
|
0
|
0
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
INFLUENCE OF VITAMIN D ON NONC...OMMUNICABLE DISEASE OUTCOMES IN SOUTH AFRICAN SCHOOLCHILDREN: THE VIDIKIDSNCD SUBSTUDY
more
|
Influence of vitamin D on nonc...ommunicable disease outcomes in South African schoolchildren: the ViDiKidsNCD substudy
more
|
Influence of vitamin D on nonc...ommunicable disease outcomes in South African schoolchildren: the ViDiKidsNCD substudy
more
|
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceec4
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019003855
|
MRC_ETH_MR/R021600/1
|
1
|
Ethiopia
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.096336
|
0.096336
|
0
|
0
|
0.096336
|
0.096336
|
0
|
0.096336
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
BUILDING A PLATFORM TO UNDERST...AND ASYMPTOMATIC AND SYMPTOMATIC VISCERAL LEISHMANIASIS IN ETHIOPIA
more
|
Building a platform to underst...and asymptomatic and symptomatic visceral leishmaniasis in Ethiopia
more
|
Building a platform to underst...and asymptomatic and symptomatic visceral leishmaniasis in Ethiopia
more
|
Leishmaniasis
|
12182
|
Medical research
|
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65675cfd212eaade2e0ceec5
|
2019
|
United Kingdom
|
Department for Business, Energ...y and Industrial Strategy
more
|
2019002719
|
GCRF_RS_AA_FLAIR_FLR\R1\190353
|
1
|
Africa, regional
|
Africa
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.127616
|
0.127616
|
0
|
0
|
0.127616
|
0.127616
|
0
|
0.127616
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
STRUCTUREBASED DESIGN OF DUAL ...INHIBITORS OF TRYPANOSOMES GLYCEROL KINASE AND ALTERNATIVE OXIDASE FOR DRUG DEVELOPMENT AGAINST AFRICAN TRYPANOSOMIASIS
more
|
Structurebased design of dual ...inhibitors of trypanosomes glycerol kinase and alternative oxidase for drug development against African trypanosomiasis
more
|
Fellowship award based in Nige...ria. Designing treatments for sleeping sickness and nagana, diseases caused by African trypanosome parasites. Annually sleeping sickness kills thousands of African people and millions of livestock animals. The project focuses on developing novel drugs that inhibit trypanosome enzymes without causing harmful side effects. SDG 3.
more
|
NTD
|
12250
|
Infectious disease control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
|
65675cfd212eaade2e0ceec6
|
2019
|
World Health Organisation
|
WHO Core Voluntary contributio...ns
more
|
2019002720
|
4.002
|
8
|
Afghanistan
|
South & Central Asia
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.0970201
|
0.0970201
|
0
|
0
|
0.0970201
|
0.0970201
|
|
|
|
|
Sector-wide health programmes
|
Health workforce
|
100
|
CVCA_625_4.2 INTEGRATED PEOPLE...-CENTRED HEALTH SERVICES
more
|
CVCA_625_4.2 Integrated people...-centred health services
more
|
Integrated people-centred heal...th services
more
|
|
12281
|
Health personnel development
|
3.8
|
I.2.b. Basic Health
|
41143
|
World Health Organisation - co...re voluntary contributions account
more
|
WHO-CVCA
|
|
3.8
|
|
65675cfd212eaade2e0ceec7
|
2019
|
World Health Organisation
|
WHO Core Voluntary contributio...ns
more
|
2019002543
|
2.001
|
8
|
Saint Vincent and the Grenadin...es
more
|
Caribbean & Central America
|
UMICs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.00242208
|
0.00242208
|
0
|
0
|
0.00242208
|
0.00242208
|
|
|
|
|
Other health problems
|
Non-communicable diseases
|
100
|
CVCA_384_2.1 NONCOMMUNICABLE D...ISEASES
more
|
CVCA_384_2.1 Noncommunicable d...iseases
more
|
Noncommunicable diseases
|
0
|
12310
|
NCDs control, general
|
3.4
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
41143
|
World Health Organisation - co...re voluntary contributions account
more
|
WHO-CVCA
|
|
3.4
|
|
65675cfd212eaade2e0ceec8
|
2019
|
World Health Organisation
|
WHO Core Voluntary contributio...ns
more
|
2019002727
|
1.003
|
8
|
Bhutan
|
South & Central Asia
|
LDCs
|
ODA Grants
|
4
|
10
|
110
|
C01
|
0.00094289
|
0.00094289
|
0
|
0
|
0.00094289
|
0.00094289
|
|
|
|
|
Communicable diseases
|
Malaria
|
100
|
CVCA_630_1.3 MALARIA
|
CVCA_630_1.3 Malaria
|
Malaria
|
0
|
12262
|
Malaria control
|
3.3
|
I.2.b. Basic Health
|
41143
|
World Health Organisation - co...re voluntary contributions account
more
|
WHO-CVCA
|
|
3.3
|
|
65675cfd212eaade2e0ceec9
|
2019
|
Switzerland
|
Cantons and municipalities
|
2019002732
|
030-Q31-2019-745
|
1
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.181123
|
0.181123
|
0
|
0
|
0.181123
|
0.181123
|
0
|
0.181123
|
0
|
0
|
Emergency projects (meeting ad...ditional funding needs)
more
|
|
100
|
AMÉLIORATION DES OPPORTUNITÉ...S EN MATIÈRE DE SANTÉ REPRODUCTIVE ET MATERNELLE POUR LES RÉFUGIÉS
more
|
Amélioration des opportunité...s en matière de santé reproductive et maternelle pour les réfugiés
more
|
|
|
13020
|
Reproductive health care
|
|
I.3. Population Policies/Progr...ammes & Reproductive Health
more
|
21000
|
International NGO
|
|
|
|
